Fusion Antibodies Ltd., a Belfast-based developer of antibody therapies for cancer, has raised Gbp1.2 million in second-round funding. Backers include Crescent Capital, Viridian Growth Fund, Quibis Ltd., University Challenge Fund and Invest Northern Ireland. www.fusionantibodies.com
TriWest Capital Partners has closed its third fund with Cdn$250 million in capital commitments. The Calgary-based firm focuses on mid-market Canadian companies with operating earnings of between Cdn$10 million and Cdn$40 million. In conjunction with the fund closing, TriWest has promoted both Chad Danard and Ryan Giles from senior associate to vice president. www.triwest.ca
Third Security of Radford, Va. has closed its fifth fund with $250 million in capital commitments, according to VentureWire. The fund is named New River Management V, and will continue to invest in both private and public companies. www.thirdsecurity.com
Dimple Sahni has agreed to join Omidyar Network, effective September 4. She has spent the past two years as a Kauffman Fellow with L Capital Partners. www.omidyar.net
Morgan Stanley said that Walid Chammah, global head of I-banking, will relocate from New York to London, and be named chief executive of Morgan Stanley International. Gavin McDonald will be named global head of M&A, where he replaces Paul Taubman. Taubman will become co-head of I-banking, alongside Cordell Spencer. www.morganstanley.com
Mark Anson, chief executive of Hermes, the fund manager owned by the 38 bln stg BT Pension Scheme, has decided to quit the firm for 'family reasons' and will join the Chicago-based fund manager Nuveen Investments as its president. Anson is understood to have decided to quit the firm after the sudden death of his […]
Curse Inc., a San Francisco-based gaming portal focused on MMOGs, has raised $5 million in Series A funding. AGF Private Equity of France led the deal, and was joined by individual angels. www.curse.com Press Release: CURSE EXPANDS WITH $5 MILLION IN FUNDING FROM AGF PRIVATE EQUITY Web 2.0 Online Game Portal Receives Series-A […]
Merck & Co. (NYSE: MRK) has agreed to acquire NovaCardia Inc., a San Diego-based drug company focused on cardiovascular disease. The deal is valued at approximately $350 million in Merck stock, plus the value of NovaCardia's cash on hand at the time of closing. NovaCardia had been in registration for an $86.25 million IPO, but […]
The Pittsburgh Life Sciences Greenhouse has added three executives-in-residence. They are: Hank Safferstein, former vice president of business development for Omrix Biopharmaceuticals; Samuel Straface, former director of the New Ventures group at Boston Scientific Corp. and David Weaver, founder and president of the Great Lakes Angels. www.plsg.com
Fortress Investment Group has closed its fifth fund with $5 billion in capital commitments. It also expects to add an additional $1 billion in capital from itself, its affiliates and its employees. The firm declined further comment, citing a pending earnings call. www.fortress.com